Page 34 - Eclipse Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Tenstorrent Raises over $200 million at $1 billion Valuation to Create Programmable, High Performance AI Computers News provided by Share this article Share this article TORONTO, May 20, 2021 /PRNewswire/ - Tenstorrent, a hardware start-up developing next generation computers, announced today that it has raised over $200 million in a recent funding round that values the company at $1 billion. The round was led by Fidelity Management and Research Company and includes additional investments from Eclipse Ventures, Epic CG and Moore Capital.  "Our goal is to continue creating AI focused hardwar...

Tenstorrent is currently working on the Grayskull AI processor, which has already been sampling with select early customers. The Grayskull architecture uses proprietary Tensix cores, with each...

University of Michigan commits $95m to Eclipse Ventures, Chengwei Ventures Premium The University of Michigan has committed a total of $95 million to the US-based venture capital firm Eclipse Ventures, and the Chinese VC Chengwei Ventures, the regents of the institution said in a statement. Continue reading this story with a subscription to DealStreetAsia. Contact us for corporate subscriptions at subs@dealstreetasia.com. Sign up for our newsletter - The Daily Brief Opt out of receiving The Daily Brief in your inbox everyday REGISTER stories_left_p...

MedCity News Cellares gets $82M to make cell therapy manufacturing automated, scalable Cell therapy manufacturing is currently a manual, multi-step process that takes weeks. Startup Cellares, which is developing a system that automates the process and makes manufacturing scalable, will use the Series B financing to accelerate its work. Shares0   Talk to enough biotech industry folks and the phrase “the product is the process” is bound to come up. It refers to cell therapies, which are made by engineering human cells. In short, the medicine is an extension of the process that produced i...